A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD
Clinical trial NCT04630860 · COMPLETED
Trial details
- NCT number
- NCT04630860
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-07
- Primary completion
- 2021-05-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.